drugset / Trial / NCT00832416

A Four-Arm Study Comparing the Analgesic Efficacy and Safety of Tramadol Once a Day 100, 200 and 300 mg Versus Placebo for the Treatment of Pain Due to Osteoarthritis of the Knee

NCT00832416

Phase 3 Completed 565 enrolled Labopharm Inc.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to compare the analgesic efficacy and safety of Tramadol Once a Day 100, 200, 300 mg and Placebo

Timeline

Start
2003-01
Primary completion
2003-08
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Tramadol Other / unclassified 100 mg
Subject Tramadol Other / unclassified 200 mg
Subject Tramadol Other / unclassified 300 mg

Indications